Look at: https://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program
The main thing in the FDA is that a drug will help the patient. 201 study targets the symptoms of the patient as does the 202 survey. If there is an improvement 434 will be approved, IMO. No phase 3 is needed. A drug needs to be safe, of course.
We got early signs of improvement ( 43% and 29%) and this is happening when only 50% of the estimated needed healing time ( 12 months) has passed supported also by MRI volumetric results. Nobody will do phase 3 with ATH434 using hundreds of MSA patients. But in PD phase 3 is needed, IMO.
This is just my opinion when reading FDA instructions.
- Forums
- ASX - By Stock
- What to hopefully look forward too
Look at:...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $5.491K | 1.520M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126437200 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 50987030 | 0.003 |
56 | 89498098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126437200 | 27 |
0.005 | 29143782 | 28 |
0.006 | 12098927 | 17 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online